v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2026
Jan. 31, 2026
Current assets    
Cash and cash equivalents $ 429,397 $ 380,196
Short-term investments 1,319,717 1,295,579
Accounts receivable, net of allowances of $546 and $299 199,344 256,773
Deferred commissions 109,910 110,651
Prepaid expenses and other current assets 165,368 180,365
Total current assets 2,223,736 2,223,564
Noncurrent assets    
Property and equipment, net 86,504 83,830
Deferred commissions, noncurrent 155,621 157,592
Goodwill 199,606 199,606
Other assets, noncurrent 102,780 101,944
Total assets 2,768,247 2,766,536
Current liabilities    
Accounts payable 14,161 15,329
Accrued expenses and other current liabilities 143,910 229,976
Deferred revenue 1,121,975 1,068,754
Total current liabilities 1,280,046 1,314,059
Deferred revenue, noncurrent 766,401 776,547
Other liabilities, noncurrent 71,334 64,771
Convertible senior notes, net 1,131,791 1,130,721
Total liabilities 3,249,572 3,286,098
Commitments and contingencies (Note 8)
Stockholders’ deficit    
Preferred stock, $0.000025 par value – $20,000,000 shares authorized as of April 30, 2026 and January 31, 2026; zero shares issued and outstanding as of April 30, 2026 and January 31, 2026 0 0
Additional paid-in capital 2,755,906 2,662,861
Accumulated other comprehensive (loss) income (9,222) 3,733
Accumulated deficit (3,228,014) (3,186,161)
Total stockholders’ deficit (481,325) (519,562)
Total liabilities and stockholders’ deficit 2,768,247 $ 2,766,536
Preferred stock, authorized (in shares)   20,000,000
Class A    
Stockholders’ deficit    
Common stock 4 $ 4
Class B    
Stockholders’ deficit    
Common stock $ 1 $ 1